(Q44675112)

5 December 2017

title

Recombinant human lactoferrin ingestion attenuates indomethacin-induced enteropathy in vivo in healthy volunteers (English)

1 reference

5 December 2017

3

1 reference

5 December 2017

F J Troost

1

1 reference

5 December 2017

W H M Saris

series ordinal

2

1 reference

5 December 2017

publication date

1 December 2003

1 reference

European Journal of Clinical Nutrition

5 December 2017

published in

1 reference

5 December 2017

volume

57

1 reference

5 December 2017

issue

12

1 reference

5 December 2017

page(s)

1579-1585

1 reference

Structure, function and flexibility of human lactoferrin.

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

Identification of the bactericidal domain of lactoferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

Intracellular calcium homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

Isolation and characterization of rhesus monkey milk lactoferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

Inhibition of lipid peroxidation by the iron-binding protein lactoferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

Visualization of lactotransferrin brush-border receptors by ligand-blotting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

In vitro antiviral activity of lactoferrin and ribavirin upon hantavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

Structure and biological actions of lactoferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

Review: The Biochemical Basis of Non-Steroidal Anti-Inflammatory Drug-Induced Damage to the Gastrointestinal Tract: A Review and a Hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

7 January 2021

Misoprostol reduces indomethacin-induced changes in human small intestinal permeability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

7 January 2021

The role of lactoferrin as an anti-inflammatory molecule

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

7 January 2021

Lactoferrin: a multifunctional immunoregulatory protein?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

7 January 2021

Gastrointestinal food hypersensitivity: basic mechanisms of pathophysiology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

7 January 2021

Bacterial chemotactic oligopeptides and the intestinal mucosal barrier

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

7 January 2021

Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

7 January 2021

Intestinal permeability changes in acute gastroenteritis: effects of clinical factors and nutritional management.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

7 January 2021

Orally administered lactoferrin exerts an antimetastatic effect and enhances production of IL-18 in the intestinal epithelium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

7 January 2021

Gastrointestinal permeability during exercise: effects of aspirin and energy-containing beverages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

7 January 2021

Molecular interactions between human lactotransferrin and the phytohemagglutinin-activated human lymphocyte lactotransferrin receptor lie in two loop-containing regions of the N-terminal domain I of human lactotransferrin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

7 January 2021

Is small intestinal permeability really increased in relatives of patients with Crohn's disease?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

7 January 2021

Sucrose: a novel permeability marker for gastroduodenal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

7 January 2021

Acute intestinal injury induced by acetic acid and casein: prevention by intraluminal misoprostol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

7 January 2021

Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

7 January 2021

Simple and sensitive multi-sugar-probe gut permeability test by high-performance liquid chromatography with fluorescence labelling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

7 January 2021

Effects of lactoferrin and lactoferricin on the release of interleukin 8 from human polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

7 January 2021

Gastrointestinal permeability in celiac disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

7 January 2021

Stress and gastrointestinal tract. II. Stress and intestinal barrier function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

7 January 2021

Gastric digestion of bovine lactoferrin in vivo in adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

7 January 2021

The sensitivity of the lactulose/rhamnose gut permeability test

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

7 January 2021

Gastric ulceration: critical events at the neutrophil--endothelium interface.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

7 January 2021

Intestinal permeability and the prediction of relapse in Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

7 January 2021

The main systemic, highly effective, and quickly acting antimicrobial mechanisms generated by lactoferrin in mammals in vivo. Activity in health and disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601727

7 January 2021

Identifiers

DOI

10.1038/SJ.EJCN.1601727

1 reference

Dimensions Publication ID

5 December 2017

1045340059

0 references

1 reference